Transcription of DIFFUSE LARGE B-CELL LYMPHOMA - World …
{{id}} {{{paragraph}}}
Example: biology
DIFFUSE LARGE B-CELL LYMPHOMA - World …
DIFFUSE LARGE B-CELL LYMPHOMA Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines 1 DIFFUSE LARGE B-CELL LYMPHOMA Executive Summary DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) is the most common subtype of non-Hodgkin LYMPHOMA (NHL), constituting up to 40% of all cases globally.[1] This subtype of cancer is heterogeneous and aggressive, yet scientific advances in the last quarter century have rendered it curable with chemotherapy or with combined chemotherapy and immunotherapy.
DIFFUSE LARGE B-CELL LYMPHOMA Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines !! ! ! 2!
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Non-Hodgkin Lymphoma/Lymphoid Neoplasms, Examination of Specimens From Patients, Nordic Protocol Maxi-CHOP and, Cytarabine) for Mantle Cell Lymphoma, Are the differences between Leukemia and, Oral Burkitt's Lymphoma - Case Report, Lymphoma Facts, Lymphoma, NCCN Clinical Practice Guidelines in Oncology